SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys

被引:0
|
作者
Fischman, AJ
Babich, JW
Elmaleh, DR
Barrow, SA
Meltzer, P
Hanson, RN
Madras, BK
机构
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02114 USA
[2] ORGANIX INC, BOSTON, MA USA
[3] NORTHEASTERN UNIV, DEPT CHEM, BOSTON, MA 02115 USA
[4] NEW ENGLAND REG PRIMATE RES CTR, SOUTHBOROUGH, MA 01772 USA
关键词
Parkinson's disease; dopamine transporters; iodine-123-IACFT; carbon-11-CFT; MPTP;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Parkinson's disease is characterized by degeneration of dopamine (DA) neurons and their terminals. Since these neurons contain dopamine transporters (DAT), radioligands that bind to these sites are promising radiopharmaceuticals for diagnosis and therapeutic monitoring of disease progression. We evaluated [I-123]-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)-N-(1 -iodoprop-1-en-3-yl)nortropane ([I-123]IACFT) for SPECT imaging in an MPTP model of parkinsonism. Methods: Three rhesus monkeys were imaged before and at 1 and 2 mo after treatment with MPTP. The SPECT results were correlated with motor behavior and PET imaging with [C-11]-2 beta-carbomethoxy-3 beta-aryltropane ([C-11] - CFT). Also, biodistribution was measured by planar imaging. Results: In normal animals, striatal accumulation of radioactivity was-rapid and peaked within 30 min. Striatal accumulation of [I-123]IACFT was nearly completely displaceable with unlabeled CFT (1 mg/kg) but was not affected by a similar dose of the serotonin (5-HT) transport inhibitor, citalopram. The striatal to cerebellar ratio measured at 30 min. after injection of [I-123]IACFT was significantly higher (p < 0.01) than with [C-11]CFT; similar to 6: 1 versus similar to 2.5: 1. After MPTP treatment this ratio decreased to 1.02:1 with IACFT and 1.23:1 with [C-11]CFT. Blood clearance of [I-123]IACFT was rapid with a terminal t(1/2) of similar to 30 min. HPLC of plasma samples demonstrated that the concentration of intact ligand decreases rapidly, approaching zero by 60 min. Low levels of accumulation were measured in extracranial tissues. Conclusion: These results demonstrate that [I-123]IACFT is an excellent SPECT ligand far dopamine transporter sites that combines the critical characteristics of: (a) high striatal to cerebellar ratios, (b) high selectivity for dopamine versus 5-HT transporter sites, (c) convenient preparation at high-specific activity and radiochemical purity and (d) a striatal localization rate that is well matched to the physical t(1/2) of I-123.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [1] PET imaging of the dopamine transporter in MPTP-treated monkeys: A window on dopamine neuron regeneration?
    Madras, BK
    Fischman, AJ
    Alpert, N
    ANNALS OF NEUROLOGY, 1997, 42 (03) : T203 - T203
  • [2] In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys
    Gerhardt, GA
    Cass, WA
    Hudson, J
    Henson, M
    Zhang, ZM
    Ovadia, A
    Hoffer, BJ
    Gash, DM
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (02) : 579 - 588
  • [3] Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
    Fernagut, Pierre-Olivier
    Li, Qin
    Dovero, Sandra
    Chan, Piu
    Wu, Tao
    Ravenscroft, Paula
    Hill, Michael
    Chen, Zhenwen
    Bezard, Erwan
    PLOS ONE, 2010, 5 (11):
  • [4] Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
    Pifl, Christian
    Hornykiewicz, Oleh
    NEUROCHEMISTRY INTERNATIONAL, 2006, 49 (05) : 519 - 524
  • [5] 6-F-18-L-DOPA IMAGING OF THE DOPAMINE NEOSTRIATAL SYSTEM IN NORMAL AND CLINICALLY NORMAL MPTP-TREATED RHESUS-MONKEYS
    DOUDET, DJ
    MIYAKE, H
    FINN, RT
    MCLELLAN, CA
    AIGNER, TG
    WAN, RQ
    ADAMS, HR
    COHEN, RM
    EXPERIMENTAL BRAIN RESEARCH, 1989, 78 (01) : 69 - 80
  • [6] SPIPERONE BINDING AND DOPAMINE LEVELS IN THE STRIATUM OF MPTP-TREATED MONKEYS
    ALEXANDER, GM
    SCHWARTZMAN, RJ
    FERRARO, TN
    ANNALS OF NEUROLOGY, 1986, 20 (01) : 149 - 149
  • [7] Long-term cognitive impairment in MPTP-treated Rhesus monkeys
    FernandezRuiz, J
    Doudet, DJ
    Aigner, TG
    NEUROREPORT, 1995, 7 (01) : 102 - 104
  • [8] A new 99m-technetium labeled ligand for SPECT imaging of dopamine transporter sites (O-15O5T): Preliminary evaluation in normal and MPTP treated monkeys.
    Fischman, AJ
    Meltzer, P
    Hillier, S
    Bonab, AA
    Callahan, RJ
    Barrow, SA
    Madras, BK
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 262P - 262P
  • [9] Neuroprotective effects of TCH346 in bilaterally MPTP-treated rhesus monkeys.
    Perentes, E
    Andringa, G
    Waldmeier, PC
    Roth, DR
    Ibrahim, M
    Cools, AR
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05): : 461 - 461
  • [10] Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys
    Raz, A
    Frechter-Mazar, V
    Feingold, A
    Abeles, M
    Vaadia, E
    Bergman, H
    JOURNAL OF NEUROSCIENCE, 2001, 21 (03):